BREAKING NEWS | TIF’s Collaboration with WHO Extended to 2027
TIF’s partnership with the World Health Organization’s (WHO) has been renewed for another term (2024-2027).
Our enduring collaboration was newly endorsed by WHO’s Executive Board at its 154th session in January 2024, demonstrating our significant and ongoing contribution to WHO’s strategic health objectives. This extension is not only a testament to TIF’s dedication to addressing health inequalities globally but also shines a proud light on the role of Cyprus in controlling haemoglobin disorders, an emerging public health threat.
Since 1996, TIF has stood alongside WHO in striving for better global health outcomes. In honour of its efforts, the Federation was awarded the prestigious Dr. Lee Jong-wook Memorial Prize for Public Health at the 68th World Health Assembly in 2015.
Our commitment is stronger than ever as we continue our mission hand in hand with WHO, delivering hope and health to those affected by thalassaemia and other haemoglobinopathies across the globe.
